Sinovac Biotech Ltd.
SVA · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $644,461 | $644,438 | $644,261 | $643,780 |
| - Cash | $1,072,350 | $1,270,131 | $1,643,026 | $4,278,124 |
| + Debt | $324,508 | $298,983 | $263,185 | $74,673 |
| Enterprise Value | -$103,381 | -$326,710 | -$735,580 | -$3,559,671 |
| Revenue | – | $307,865 | $140,404 | $280,471 |
| % Growth | – | 119.3% | -49.9% | – |
| Gross Profit | – | $307,865 | -$48,005 | -$149,623 |
| % Margin | – | 100% | -34.2% | -53.3% |
| EBITDA | – | -$26,832 | $20,803 | -$999,623 |
| % Margin | – | -8.7% | 14.8% | -356.4% |
| Net Income | – | -$116,836 | $16,918 | -$370,646 |
| % Margin | – | -38% | 12% | -132.2% |
| EPS Diluted | – | -1.17 | 0.15 | -3.73 |
| % Growth | – | -880% | 104% | – |
| Operating Cash Flow | – | $146,009 | -$39,991 | $151,773 |
| Capital Expenditures | – | -$52,746 | -$92,942 | -$149,995 |
| Free Cash Flow | – | $93,263 | -$132,933 | $1,778 |